Caris Life Sciences, Inc.
CAINasdaq
$16.49
↑ +0.1%Jul 17 close · end-of-day
Price
1Y↓ -47.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$4.7B
Enterprise Value
$4.2B
P/E
47.1
P/S
5.1
P/B
7.9
EV/EBITDA
32.7
PEG
—
FCF Yield
2.6%
Dividend Yield
—
Revenue (TTM)
$907.3M
Net Income (TTM)
$34.0M
Free Cash Flow (TTM)
$123.5M
Gross Margin
—
Operating Margin
11.9%
Net Margin
3.8%
ROE
5.7%
ROIC
70.9%
Debt / Equity
0.6
Net Cash
$440.6M
Return 1Y
-47.3%
Company profile
We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our principal executive offices are located in Irving, Texas.
- CEO
- David D. Halbert
- Sector
- Services
- Industry
- Healthcare
- Employees
- 1,769
- Headquarters
- TX
- Website
- www.carislifesciences.com
Management & directors
- Brille Brian JSee Remarks
- Denton John RusselSee Remarks
- Halbert David DSee Remarks
- Power Luke ThomasSee Remarks
- Spetzler David BaxleyPresident
Roles derived from SEC Form 4 filings.
Earnings
CAI Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$216.2M↑ +78.8%
Diluted EPS$0.00↓ -100.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $306.1M | $412.3M | $812.0M |
| Gross profit | — | — | — |
| Operating income | -$319.6M | -$257.1M | $45.1M |
| Net income | -$341.4M | -$281.9M | -$68.1M |
| Diluted EPS | -$13.24 | -$10.66 | -$3.22 |
| Operating cash flow | -$276.1M | -$245.2M | $83.2M |
| Free cash flow | -$298.4M | -$253.6M | $66.9M |
| Gross margin | — | — | — |
| Operating margin | -104.4% | -62.4% | 5.6% |
| Net margin | -111.5% | -68.4% | -8.4% |
| Line item | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Revenue | $100.0M | $101.6M | $120.9M | $181.4M | $216.8M | $292.9M | $216.2M |
| Gross profit | — | — | — | — | — | — | — |
| Operating income | -$67.0M | -$60.8M | -$58.0M | -$18.0M | $32.6M | $88.4M | $5.3M |
| Net income | -$66.2M | -$67.7M | -$102.6M | -$71.8M | $24.3M | $82.0M | -$510,000.00 |
| Diluted EPS | -$2.54 | -$2.59 | -$3.57 | -$7.97 | $0.08 | $8.24 | $0.00 |
| Operating cash flow | — | -$69.4M | -$31.3M | $7.3M | $62.4M | $44.8M | $32.9M |
| Free cash flow | — | -$71.3M | -$34.0M | $5.9M | $55.3M | $39.7M | $22.5M |
| Gross margin | — | — | — | — | — | — | — |
| Operating margin | -67.0% | -59.9% | -47.9% | -9.9% | 15.1% | 30.2% | 2.4% |
| Net margin | -66.2% | -66.6% | -84.8% | -39.6% | 11.2% | 28.0% | -0.2% |
Company news
Jul 17, 2026
Jul 16, 2026
Jul 10, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-29 | Knowles Jonathan Kenneth Charles | Award | 1,600 | $15.62 | $24,992.00 | filing |
| 2026-05-29 | POSTE GEORGE | Award | 1,600 | $15.62 | $24,992.00 | filing |
| 2026-05-15 | HALBERT JON | Buy | 68,000 | $14.56 | $990,080.00 | filing |
| 2026-05-15 | HALBERT DAVID D· See Remarks | Tax withholding | 40,712 | $15.25 | $620,858.00 | filing |
| 2026-05-15 | Brille Brian J· See Remarks | Tax withholding | 13,987 | $15.25 | $213,301.75 | filing |
| 2026-05-15 | Spetzler David Baxley· President | Tax withholding | 13,856 | $15.25 | $211,304.00 | filing |
| 2026-05-15 | Power Luke Thomas· See Remarks | Tax withholding | 9,771 | $15.25 | $149,007.75 | filing |
| 2026-05-15 | Denton John Russel· See Remarks | Tax withholding | 6,047 | $15.25 | $92,216.75 | filing |
| 2026-05-11 | Vacirca Jeff L | Buy | 31,050 | $16.15 | $501,426.45 | filing |
| 2026-03-06 | HALBERT DAVID D· See Remarks | Award | 320,112 | $0.00 | $0.00 | filing |
| 2026-03-06 | Power Luke Thomas· See Remarks | Award | 63,971 | $0.00 | $0.00 | filing |
| 2026-03-06 | Denton John Russel· See Remarks | Award | 63,971 | $0.00 | $0.00 | filing |
| 2026-03-06 | Spetzler David Baxley· President | Award | 83,162 | $0.00 | $0.00 | filing |
| 2026-03-06 | Brille Brian J· See Remarks | Award | 83,162 | $0.00 | $0.00 | filing |
| 2026-02-26 | CASTLEMAN PETER M | Award | 5,509 | $20.06 | $110,510.54 | filing |
| 2026-02-26 | PHILLIPS T DANNY | Award | 3,739 | $20.06 | $75,004.34 | filing |
| 2026-02-26 | Minor Lloyd | Award | 2,492 | $20.06 | $49,989.52 | filing |
| 2026-02-26 | Vacirca Jeff L | Award | 2,492 | $20.06 | $49,989.52 | filing |
| 2026-02-26 | Fredrickson David Paul | Award | 2,492 | $20.06 | $49,989.52 | filing |
| 2026-02-26 | HALBERT JON | Award | 2,492 | $20.06 | $49,989.52 | filing |
| 2026-01-09 | CASTLEMAN PETER M | Option exercise | 2,500 | $18.60 | $46,500.00 | filing |
| 2025-12-11 | Power Luke Thomas· See Remarks | Sale | 60,850 | $26.56 | $1.6M | filing |
| 2025-12-11 | Power Luke Thomas· See Remarks | Option exercise | 37,500 | $2.44 | $91,500.00 | filing |
| 2025-12-11 | Power Luke Thomas· See Remarks | Option exercise | 24,750 | $2.44 | $60,390.00 | filing |
| 2025-12-11 | Power Luke Thomas· See Remarks | Sale | 1,400 | $27.16 | $38,017.56 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.